2021 ICD-10-CM Code C96

Other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue

Version 2021

Not Valid for Submission

C96 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue. The code is not specific and is NOT valid for the year 2021 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.

Unspecified diagnosis codes like C96 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.

ICD-10:C96
Short Description:Oth & unsp malig neoplm of lymphoid, hematpoetc and rel tiss
Long Description:Other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue

Code Classification

Specific Coding for Oth & unsp malig neoplm of lymphoid, hematpoetc and rel tiss

Non-specific codes like C96 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10 codes with a higher level of specificity when coding for oth & unsp malig neoplm of lymphoid, hematpoetc and rel tiss:

  • BILLABLE CODE - Use C96.0 for Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis
  • NON-BILLABLE CODE - C96.2 for Malignant mast cell neoplasm
  • BILLABLE CODE - Use C96.20 for Malignant mast cell neoplasm, unspecified
  • BILLABLE CODE - Use C96.21 for Aggressive systemic mastocytosis
  • BILLABLE CODE - Use C96.22 for Mast cell sarcoma
  • BILLABLE CODE - Use C96.29 for Other malignant mast cell neoplasm
  • BILLABLE CODE - Use C96.4 for Sarcoma of dendritic cells (accessory cells)
  • BILLABLE CODE - Use C96.5 for Multifocal and unisystemic Langerhans-cell histiocytosis
  • BILLABLE CODE - Use C96.6 for Unifocal Langerhans-cell histiocytosis
  • BILLABLE CODE - Use C96.9 for Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified
  • BILLABLE CODE - Use C96.A for Histiocytic sarcoma
  • BILLABLE CODE - Use C96.Z for Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue

Tabular List of Diseases and Injuries

The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code C96:


Type 1 Excludes

Type 1 Excludes
A type 1 excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.

Information for Patients


Leukemia

Leukemia is cancer of the white blood cells. White blood cells help your body fight infection. Your blood cells form in your bone marrow. In leukemia, the bone marrow produces abnormal white blood cells. These cells crowd out the healthy blood cells, making it hard for blood to do its work.

There are different types of leukemia, including

Leukemia can develop quickly or slowly. Chronic leukemia grows slowly. In acute leukemia, the cells are very abnormal and their number increases rapidly. Adults can get either type; children with leukemia most often have an acute type.Some leukemias can often be cured. Other types are hard to cure, but you can often control them. Treatments may include chemotherapy, radiation and stem cell transplantation. Even if symptoms disappear, you might need therapy to prevent a relapse.

NIH: National Cancer Institute


[Learn More in MedlinePlus]

Lymphoma

Also called: Non-Hodgkin lymphoma

Lymphoma is a cancer of a part of the immune system called the lymph system. There are many types of lymphoma. One type is Hodgkin disease. The rest are called non-Hodgkin lymphomas.

Non-Hodgkin lymphomas begin when a type of white blood cell, called a T cell or B cell, becomes abnormal. The cell divides again and again, making more and more abnormal cells. These abnormal cells can spread to almost any other part of the body. Most of the time, doctors don't know why a person gets non-Hodgkin lymphoma. You are at increased risk if you have a weakened immune system or have certain types of infections.

Non-Hodgkin lymphoma can cause many symptoms, such as

Your doctor will diagnose lymphoma with a physical exam, blood tests, a chest x-ray, and a biopsy. Treatments include chemotherapy, radiation therapy, targeted therapy, biological therapy, or therapy to remove proteins from the blood. Targeted therapy uses substances that attack cancer cells without harming normal cells. Biologic therapy boosts your body's own ability to fight cancer. If you don't have symptoms, you may not need treatment right away. This is called watchful waiting.

NIH: National Cancer Institute


[Learn More in MedlinePlus]

Code History

  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)